These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1940 related items for PubMed ID: 28235848

  • 1. Patients With Long-QT Syndrome Caused by Impaired hERG-Encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated With Reactive Hypoglycemia.
    Hyltén-Cavallius L, Iepsen EW, Wewer Albrechtsen NJ, Svendstrup M, Lubberding AF, Hartmann B, Jespersen T, Linneberg A, Christiansen M, Vestergaard H, Pedersen O, Holst JJ, Kanters JK, Hansen T, Torekov SS.
    Circulation; 2017 May 02; 135(18):1705-1719. PubMed ID: 28235848
    [Abstract] [Full Text] [Related]

  • 2. Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses.
    Engelbrechtsen L, Mahendran Y, Jonsson A, Gjesing AP, Weeke PE, Jørgensen ME, Færch K, Witte DR, Holst JJ, Jørgensen T, Grarup N, Pedersen O, Vestergaard H, Torekov S, Kanters JK, Hansen T.
    BMC Genet; 2018 Mar 16; 19(1):15. PubMed ID: 29548277
    [Abstract] [Full Text] [Related]

  • 3. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
    Tura A, Bagger JI, Ferrannini E, Holst JJ, Knop FK, Vilsbøll T, Mari A.
    Nutr Metab Cardiovasc Dis; 2017 Dec 16; 27(12):1123-1129. PubMed ID: 29162361
    [Abstract] [Full Text] [Related]

  • 4. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.
    J Clin Endocrinol Metab; 2003 Jun 16; 88(6):2706-13. PubMed ID: 12788877
    [Abstract] [Full Text] [Related]

  • 5. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ.
    J Clin Endocrinol Metab; 2003 Oct 16; 88(10):4897-903. PubMed ID: 14557471
    [Abstract] [Full Text] [Related]

  • 6. Incretin levels in polycystic ovary syndrome.
    Vrbikova J, Hill M, Bendlova B, Grimmichova T, Dvorakova K, Vondra K, Pacini G.
    Eur J Endocrinol; 2008 Aug 16; 159(2):121-7. PubMed ID: 18511472
    [Abstract] [Full Text] [Related]

  • 7. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
    Hansen KB, Vilsbøll T, Bagger JI, Holst JJ, Knop FK.
    J Clin Endocrinol Metab; 2012 Apr 16; 97(4):1363-70. PubMed ID: 22319034
    [Abstract] [Full Text] [Related]

  • 8. Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
    Carr RD, Larsen MO, Winzell MS, Jelic K, Lindgren O, Deacon CF, Ahrén B.
    Am J Physiol Endocrinol Metab; 2008 Oct 16; 295(4):E779-84. PubMed ID: 18612044
    [Abstract] [Full Text] [Related]

  • 9. Risk Stratification of Type 2 Long-QT Syndrome Mutation Carriers With Normal QTc Interval: The Value of Sex, T-Wave Morphology, and Mutation Type.
    Platonov PG, McNitt S, Polonsky B, Rosero SZ, Kutyifa V, Huang A, Moss AJ, Zareba W.
    Circ Arrhythm Electrophysiol; 2018 Jul 16; 11(7):e005918. PubMed ID: 30012873
    [Abstract] [Full Text] [Related]

  • 10. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
    Rask E, Olsson T, Söderberg S, Holst Jj Jj, Tura A, Pacini G, Ahrén B.
    Metabolism; 2004 May 16; 53(5):624-31. PubMed ID: 15131768
    [Abstract] [Full Text] [Related]

  • 11. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects.
    Swan H, Viitasalo M, Piippo K, Laitinen P, Kontula K, Toivonen L.
    J Am Coll Cardiol; 1999 Sep 16; 34(3):823-9. PubMed ID: 10483966
    [Abstract] [Full Text] [Related]

  • 12. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE, Meier JJ.
    Diabetes; 2008 Mar 16; 57(3):678-87. PubMed ID: 18057091
    [Abstract] [Full Text] [Related]

  • 13. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
    Schou JH, Pilgaard K, Vilsbøll T, Jensen CB, Deacon CF, Holst JJ, Vølund A, Madsbad S, Vaag AA.
    J Clin Endocrinol Metab; 2005 Aug 16; 90(8):4912-9. PubMed ID: 15899957
    [Abstract] [Full Text] [Related]

  • 14. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia.
    Toft-Nielsen M, Madsbad S, Holst JJ.
    Diabetologia; 1998 Oct 16; 41(10):1180-6. PubMed ID: 9794105
    [Abstract] [Full Text] [Related]

  • 15. Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes.
    Alsalim W, Tura A, Pacini G, Omar B, Bizzotto R, Mari A, Ahrén B.
    Diabetes Obes Metab; 2016 Jan 16; 18(1):24-33. PubMed ID: 26354383
    [Abstract] [Full Text] [Related]

  • 16. Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.
    Idorn T, Knop FK, Jørgensen M, Holst JJ, Hornum M, Feldt-Rasmussen B.
    Nephrol Dial Transplant; 2014 Jan 16; 29(1):119-27. PubMed ID: 24078334
    [Abstract] [Full Text] [Related]

  • 17. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
    Christensen M, Calanna S, Sparre-Ulrich AH, Kristensen PL, Rosenkilde MM, Faber J, Purrello F, van Hall G, Holst JJ, Vilsbøll T, Knop FK.
    Diabetes; 2015 Jan 16; 64(1):72-8. PubMed ID: 25053587
    [Abstract] [Full Text] [Related]

  • 18. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.
    Pederson RA, Satkunarajah M, McIntosh CH, Scrocchi LA, Flamez D, Schuit F, Drucker DJ, Wheeler MB.
    Diabetes; 1998 Jul 16; 47(7):1046-52. PubMed ID: 9648827
    [Abstract] [Full Text] [Related]

  • 19. The incretin effect in critically ill patients: a case-control study.
    Nielsen ST, Janum S, Krogh-Madsen R, Solomon TP, Møller K.
    Crit Care; 2015 Nov 16; 19():402. PubMed ID: 26567860
    [Abstract] [Full Text] [Related]

  • 20. Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
    de Jesús Garduno-Garcia J, Gastaldelli A, DeFronzo RA, Lertwattanarak R, Holst JJ, Musi N.
    J Clin Endocrinol Metab; 2018 Jul 01; 103(7):2613-2619. PubMed ID: 29672742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 97.